Business
PHBI - Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard
PHBI - Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard.
About this update from Pharmagreen Biotech Inc.
[{"type":"text","content":"\n\n\n\nPHBI - Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPHBI - Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard\nPR Newswire\nCARSON CITY, Nev., Dec. 9, 2021\n\n\n\nCARSON CITY, Nev., Dec. 9, 2021 /PRNewswire/ -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today released a second management update form CEO Peter Wojcik.  Today's update provides further information on the company's strategy to convert the revenue potential of its proprietary intellectual property into realized revenue.  The first update can be reviewed and the following link:\nPharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset  \nToday's update is included in its entirety below:\nCEO Peter Wojcik Strategic Update\nThe transition of Pharmagreen's revenue potential derived from its proven intellectual property asset will be built on the foundation of executive talent that has converged at Pharmagreen to transform the cannabis industry by making Pharmagreen's proprietary tissue culture the industry standard for industrial grow operations. \nPharmagreen has a proprietary tissue culture process called \"Chibafreen\" that can be applied to the cannabis industry to increase the scalability of industrial grow operations at the same time preserving genetic purity and enhancing quality production.\nSee my update published last week to learn more about our Chibafreen proprietary process.\nAs the Pharmagreen CEO, I am approaching the cannabis industry with Chibafreen as an economic change agent for the cannabis industry.  Yes, Chibafreen is a differentiator for Pharmagreen as a proprietary technology, but its value will be realized and monetized through its potential to positively impact the economics of the cannabis industry with the improved efficiencies that it can deliver.\nI bring to Pharmagreen a strong history of economics knowledge and experience that I have leveraged to develop a strong busines strategy for ...